Lipoproteins - Blood
Research News and Information

Saturday, November 21, 2009

Prediction of proliferative diabetic retinopathy with hemoglobin level.

30 Oct 2009 OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes ... Read more...

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

29 Sep 2009 Elevated plasma triglyceride levels represent a risk factor for premature atherosclerosis. In mice, accumulation of triglyceride-rich lipoproteins can occur if sulfation of heparan sulfate in hepatocytes is diminished, as this alters hepatic ... Read more...

Plasma levels of lipoprotein (a) in patients with major depressive disorders.

8 Sep 2009 Depression and cardiovascular disease are among the most prevalent health problems. The evidence that depression is a risk factor for the development and progression of coronary heart disease has strengthened over the past several years, but the ... Read more...

Latest indexed articles for 'Lipoproteins - Blood'

These are the very latest articles for this heading:

• Prediction of proliferative diabetic retinopathy with hemoglobin level. 30 Oct 2009
• Letter by Ala-Korpela et al regarding article, "Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women". 25 Oct 2009
• Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. 29 Sep 2009
• Limitations of automated remnant lipoprotein cholesterol assay for diagnostic use. 15 Sep 2009
• Plasma levels of lipoprotein (a) in patients with major depressive disorders. 8 Sep 2009
• Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells. 18 Aug 2009
• Cholesterol was healthy in the end. 15 Aug 2009
• Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. 4 Aug 2009
• Evaluation of multiplexed hollow fiber flow field-flow fractionation for semi-preparative purposes. 4 Aug 2009
• Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels. 30 Jul 2009
• Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote. 30 Jul 2009
• A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation. 30 Jul 2009
• Application of poly(dimethylsiloxane)/glass microchip for fast electrophoretic separation of serum small, dense low-density lipoprotein. 25 Jul 2009
• Lack of evidence for antiatherogenic effects of wheat bran or corn bran in apolipoprotein E-knockout mice. 20 Jul 2009
• Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. 13 Jul 2009
• Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects. 7 Jul 2009
• Teucrium polium in prevention of steatohepatitis in rats. 5 Jul 2009
• Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. 29 Jun 2009
• Images, lipoproteins, drugs, and atherothrombotic events. 29 Jun 2009
• Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Lipoproteins'

Definition: Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. The large lipoproteins (CHYLOMICRONS; VLDL) are to transport triglycerides, and the small lipoproteins (LDL; HDL) are to transport cholesterol.

Registry Number: 0

Descriptor UI: D008074

Alternative terms: Lipoproteins; Circulating Lipoproteins; Lipoproteins, Circulating; Lipoprotein;

Related Mesh Headings: Apolipoproteins; Hyperlipoproteinemias; Hypolipoproteinemias; Lipoid Proteinosis of Urbach and Wiethe; Proteolipids; Receptors, Lipoprotein;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532; D12.776.521;

Technical Notes: general or unspecified; prefer specifics; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIAS & specifics